Direxion Resuscitates Leveraged Pharmaceutical ETF
Direxion has revived one of its previously shuttered leveraged ETF ideas and increased the stakes on its original design. On Wednesday, Direxion…
PILL
Drug Makers, Pharma ETFs Face a Tough Earnings Season
The healthcare sector has been lackluster this earnings season, and without supporting factors such as price increases or increased mergers and acquisitions…
Direxion Debuts Double Leveraged Cyber Security, Pharmaceuticals ETFs
Direxion, the second-largest issuer of inverse and leveraged exchange traded funds, is making another big addition to its leveraged stable today with…